Protect Your Ideas

Photo: Courtesy of Raymond Fersko In the movie, Unforgiven, William Munny, the hardened gunfighter played by Clint Eastwood, remains standing after a high-mortality gunfight. The timid reporter who witnessed the shooting comes out of hiding and stutters while referring to one of the deceased: "He was unarmed." The gunfighter's taciturn reply: "He should've armed himself." The moral is clear. Science is no more immune to dishonesty or to unfair pressures and practices than are other disciplin

Written byRaymond Fersko
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In the movie, Unforgiven, William Munny, the hardened gunfighter played by Clint Eastwood, remains standing after a high-mortality gunfight. The timid reporter who witnessed the shooting comes out of hiding and stutters while referring to one of the deceased: "He was unarmed." The gunfighter's taciturn reply: "He should've armed himself."

The moral is clear.

Science is no more immune to dishonesty or to unfair pressures and practices than are other disciplines. To preempt disputes, insist on mutual written disclosure of each party's existing intellectual property rights before signing a new agreement. This includes intellectual property owned individually, jointly, beneficially, partially, or subject to a condition pursuant to license, assignment, security interest, or any other arrangement creating ownership rights. Intellectual property includes prior ideas, patents, trade secrets, technical information, and know-how. Continuing disclosure of all information bearing upon intellectual property (e.g., grant or denial of patents, and information regarding validity or ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies